Morphological and functional changes in the thyroid gland in patients with amiodarone-induced hypothyroidism

Cover Page

Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription Access

Abstract

Amiodarone is the drug of choice to treat most types of arrhythmias. Taking the drug sometimes has a significant effect on the function of the thyroid gland, causing the development of amiodarone-induced thyroid disorders, including hypothyroidism. According to the study, amiodarone-induced hypothyroidism developed in 26.1% of all thyroid disorders within 14.2±1.5 months from the start of the drug. Most often, it was diagnosed with overweight individuals who received intravenous administration of the drug over 2 times a year, with a long history of thyroid disease.

About the authors

S. V. Chernavsky

The N.N.Burdenko Main Military Clinical Hospital of the Ministry of Defense of the Russian Federation; Russian Medical Academy of Continuous Professional Education, Ministry of Health of the Russian Federation

Author for correspondence.
Email: chernavskijsv@mail.ru
Russian Federation, Moscow; Moscow

D. V. Davydov

The N.N.Burdenko Main Military Clinical Hospital of the Ministry of Defense of the Russian Federation; Peoples’ Friendship University of Russia

Email: chernavskijsv@mail.ru
Russian Federation, Moscow; Moscow

A. G. Borisov

The N.N.Burdenko Main Military Clinical Hospital of the Ministry of Defense of the Russian Federation; Russian Medical Academy of Continuous Professional Education, Ministry of Health of the Russian Federation

Email: chernavskijsv@mail.ru
Russian Federation, Moscow; Moscow

A. A. Stremoukhov

2Russian Medical Academy of Continuous Professional Education, Ministry of Health of the Russian Federation

Email: chernavskijsv@mail.ru
Russian Federation, Moscow

A. V. Dorokhina

The N.N.Burdenko Main Military Clinical Hospital of the Ministry of Defense of the Russian Federation

Email: chernavskijsv@mail.ru
Russian Federation, Moscow

O. V. Artyushkevich

The N.N.Burdenko Main Military Clinical Hospital of the Ministry of Defense of the Russian Federation

Email: chernavskijsv@mail.ru
Russian Federation, Moscow

L. A. Kudentsova

The N.N.Burdenko Main Military Clinical Hospital of the Ministry of Defense of the Russian Federation

Email: chernavskijsv@mail.ru
Russian Federation, Moscow

References

  1. Адашева Т.В., Демичева О.Ю. Кордарон и тиреоидная патология. Мифы и реальность // Мед. вестн. – 2013. – № 17. – С. 12–13.
  2. Голицын С.П. Амиодарон десятилетия спустя // Тер. арх. – 2011. – Т. 83, № 8. – С. 25–33.
  3. Гринева Е.Н., Цой У.А., Каронова Т.Л. и др. Проект федеральных клинических рекомендаций по диагностике и лечению амиодарониндуцированной дисфункции щитовидной железы // Клин. и эксперимент. тиреоидология. – 2020. – Т. 16, № 20. – С. 12–24.
  4. Крюков Е.В., Потехин Н.П., Фурсов А.Н. и др. Алгоритм ведения пациентов, получающих амиодарон, в зависимости от функционального состояния щитовидной железы // Клин. медицина. – 2017. – Т. 95, № 10. – С. 901–904.
  5. Фадеев В.В. Современные концепции диагностики и лечения гипотиреоза у взрослых // Пробл. эндокринол. – 2004. – № 2. – С. 47–55.
  6. Igonin V.A., Proskurin M.V., Serebrennikov V.N. Amiodarone-associated thyrotoxicosis: the complexity of diagnosis and treatment // Klinicheskaya tireoidologiya. – 2004. – Vol. 2, N 4. – P. 53–55.
  7. Klein I., Ojamaa K. Thyroid hormone and the cardiovascular system // N. Engl. J. Med. – 2001. – Vol. 344, N 7. – P. 501–509.

Supplementary files

Supplementary Files
Action
1. JATS XML

Copyright (c) 2022 Chernavsky S.V., Davydov D.V., Borisov A.G., Stremoukhov A.A., Dorokhina A.V., Artyushkevich O.V., Kudentsova L.A.



СМИ зарегистрировано Федеральной службой по надзору в сфере связи, информационных технологий и массовых коммуникаций (Роскомнадзор).
Регистрационный номер и дата принятия решения о регистрации СМИ: № 01975 от 30.12.1992.

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies